Category: Pancreatic (6)

Order by:


Mesenchymal Stem Cells Treating Pig Diabetes

Wuhan, China -

Mesenchymal stem cells are most likely to be the first clinically approved stem cell type in the United States for non-hematopoietic conditions, with several clinical trials in mid to late Phase III.  Mesenchymal stem cells are attractive because they can be used in a "universal donor" fashion, in part due to their immune modulatory...

Tuesday November 4th, 2008 @ 12:39:02 EST 1 Comment

Mesenchymal Stem Cells Reverse Diabetes in C57 Strep Model

Santiago, Chile -

A recent paper (Ezquer et al. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant 008 Jun;14(6):631-40) described the therapeutic impact of bone marrow derived mesenchymal stem cells administered to mice with experimental...

Wednesday May 21st, 2008 @ 11:06:10 EST

Interview with Novocell CEO Alan Lewis

[Watch the Video]

In this StemCellPatents.com interview, our special guest interviewer, Thomas Ichim, CEO of Medistem, speaks with Alan Lewis, CEO of Novocell, regarding the company's advances towards curing diabetes. This interview examines many aspects of Novocell...

Tuesday April 29th, 2008 @ 23:38:49 EST

Clinical trial for diabetes using autologous cord blood

Gainsville, Florida -

Autologous cord blood has received some recent media for its use in treatment of cerebral palsy.  Other groups have reported the use of allogeneic cord blood to have positive effects for conditions other than hematopoietic disorders, even in absence of immune...


CD133 glycosylated epitope of prominin-1 is marker for pancreatic stem cells

Brussels, Belgium - Numerous tissue have been described to have endogenous, tissue resident, stem cells. For example, cardiac tissues express a population of lineage negative, side population cells that can regenerate myocardium. These cells and their uses are claimed in US patent 7,097,833. The side population phenotype has...

Tuesday January 15th, 2008 @ 12:33:21 EST

Bone Marrow Mesenchymal Stem Cells Made to Produce Insulin

Taipei, Taiwan - In addition to their known ability to differentiate into muscle, bone, and neuronal cells, mesenchymal stem cells have been demonstrated to have the ability to differentiate into Monday December 17th, 2007 @ 03:38:27 EST 2 Comments


Order by:


Home | News | Patents | Products | Jobs | Links | Search | Journal | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2025 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.04

Stouffville Concrete | Tottenham Concrete | Uxbridge Concrete | Gerogetown Concrete | Rockwood Concrete | Kleinburg Concrete | Breslau Concrete | Kitchener Concrete | Cambridge Concrete | Caledon Concrete | Milton Concrete | King City Concrete | Mount Albert Concrete | Nobleton Concrete | Bolton Concrete | Stouffville Real Estate Agent